Radiation Therapy Practice Patterns for Brain Metastases in the United States in the Stereotactic Radiosurgery Era

by Andrew B. Barbour, PhD, Corbin D. Jacobs, MD, Hannah Williamson, MS, Scott R. Floyd, MD, PhD, Gita Suneja, MD, MS, Jordan A. Torok, MD, John P. Kirkpatrick, MD, PhD
Published 2020-01-01

The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicity

by Rachel B. Jimenez, MD, Brian M. Alexander, MD, MPH, Anand Mahadevan, MD, Andrzej Niemierko, PhD, Selvan Rajakesari, MD, Nils D. Arvold, MD, Scott R. Floyd, MD, PhD, Kevin S. Oh, MD, Jay S. Loeffler, MD, Helen A. Shih, MD
Published 2017-07-01

Outcomes in Patients With 4 to 10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective Study

by Grace J. Kim, MD, PhD, Evan D. Buckley, MS, James E. Herndon, PhD, Karen J. Allen, NP, Tyketra S. Dale, NP, Justus D. Adamson, PhD, Lam Lay, BA, William M. Giles, PhD, Anna E. Rodrigues, PhD, Zhiheng Wang, PhD, Chris R. Kelsey, MD, Jordan A. Torok, Jr, MD, Junzo P. Chino, MD, Peter E. Fecci, MD, PhD, John H. Sampson, MD, PhD, MBA, Carey K. Anders, MD, Scott R. Floyd, MD, PhD, Fang-Fang Yin, PhD, John P. Kirkpatrick, MD, PhD
Published 2021-11-01